2006
DOI: 10.1038/sj.npp.1301159
|View full text |Cite
|
Sign up to set email alerts
|

Neural Substrates of Psychostimulant-Induced Arousal

Abstract: Extensive research has provided substantial insight into the neurobiological mechanisms underlying the reinforcing, locomotor-activating and stereotypy-inducing actions of psychostimulants. The diverse behavioral effects of these drugs are superimposed on potent arousalenhancing actions. Psychostimulant-induced arousal is a prominent contributing factor to the widespread use and abuse of these drugs. Moreover, enhanced arousal may be a critical component of the reinforcing and other behavioral actions of these… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
66
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 80 publications
(71 citation statements)
references
References 67 publications
4
66
0
Order By: Relevance
“…Conversely, the fact that clinically relevant doses of psychostimulants exert only a modest impact on circuitry associated with psychostimulant-induced arousal (eg, MSA NE; Berridge, 2006) and motor activation (eg, NAc; Kelley et al, 1989) is consistent with their minimal arousal-promoting and motor-activating effects. Moreover, the fact that clinically relevant doses of psychostimulants exert a modest impact on DA levels in the NAc, a key region involved in the reinforcing effects of psychostimulants, is also consistent with evidence indicating that the clinical use of psychostimulants does not increase, and may reduce, the liability for drug abuse in ADHD populations (Biederman, 2003).…”
Section: The Pharmacology Of Adhd: Preferential Targeting Of the Pfcmentioning
confidence: 89%
“…Conversely, the fact that clinically relevant doses of psychostimulants exert only a modest impact on circuitry associated with psychostimulant-induced arousal (eg, MSA NE; Berridge, 2006) and motor activation (eg, NAc; Kelley et al, 1989) is consistent with their minimal arousal-promoting and motor-activating effects. Moreover, the fact that clinically relevant doses of psychostimulants exert a modest impact on DA levels in the NAc, a key region involved in the reinforcing effects of psychostimulants, is also consistent with evidence indicating that the clinical use of psychostimulants does not increase, and may reduce, the liability for drug abuse in ADHD populations (Biederman, 2003).…”
Section: The Pharmacology Of Adhd: Preferential Targeting Of the Pfcmentioning
confidence: 89%
“…These short term effects and the mechanisms that mediate them have been extensively studied. Amphetamine and related compounds are used recreationally in part because of such effects (reviewed in Berridge, 2006;Robinson and Berridge, 1993;Segal and Kuczenski, 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Acute METH exposure in mammals induces wakefulness attributable, in part, to increased dopaminergic signaling (8,18). We have shown previously that METH-induced arousal correlates with increased dopaminergic signaling in Drosophila (12).…”
Section: Meth-induced Wakefulness Does Not Involve Modulation Of Dda1mentioning
confidence: 99%
“…D1-like receptors in mammals mediate the wake-promoting and motor-activating properties of psychostimulants such as cocaine and amphetamines (8,(16)(17)(18). CAFF leads to increased dopaminergic transmission by antagonizing A1 receptors on presynaptic dopaminergic neurons (19).…”
Section: Adenosinergic and Dopaminergic Systems Mediate Wake-promotingmentioning
confidence: 99%